van der Laan Anja M, Piek Jan J, van Royen Niels
Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Nat Rev Cardiol. 2009 Aug;6(8):515-23. doi: 10.1038/nrcardio.2009.103. Epub 2009 Jun 16.
Since early reperfusion therapy for patients with acute myocardial infarction (AMI) was demonstrated to decrease mortality, numerous improvements in AMI management have focused on prompt reperfusion of the epicardial coronary arteries. However, in a substantial group of patients with AMI, reperfusion of the myocardial tissue is hindered by dysfunction of the microvasculature, despite successful restoration of the epicardial coronary flow. These patients have prolonged ischemia and an adverse clinical outcome. Although several studies investigating the etiology of microvascular dysfunction have been performed, little is known about the restoration process of microvascular dysfunction after reperfused AMI. The objective of this Review is to summarize our knowledge on natural restoration of the microvasculature after reperfused AMI, particularly with regard to angiogenesis, discuss diagnostic modalities used to identify patients with microvascular dysfunction and highlight the potential of pharmacological and cellular interventions to stimulate the recovery of the microvasculature by promoting angiogenesis.
由于急性心肌梗死(AMI)患者的早期再灌注治疗已被证明可降低死亡率,AMI管理方面的众多改进都集中在心外膜冠状动脉的快速再灌注上。然而,在相当一部分AMI患者中,尽管心外膜冠状动脉血流已成功恢复,但心肌组织的再灌注却因微血管功能障碍而受阻。这些患者存在长时间的缺血且临床结局不良。尽管已经开展了多项研究来探究微血管功能障碍的病因,但对于再灌注后AMI微血管功能障碍的恢复过程却知之甚少。本综述的目的是总结我们对再灌注后AMI微血管自然恢复的认识,尤其是关于血管生成方面,讨论用于识别微血管功能障碍患者的诊断方法,并强调通过促进血管生成来刺激微血管恢复的药理学和细胞干预措施的潜力。